White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation

Body fluid biomarkers have great potential for different clinical purposes, including diagnosis, prognosis, patient stratification and treatment effect monitoring. This is exemplified by current use of several excellent biomarkers, such as the Alzheimer’s disease cerebrospinal fluid (CSF) biomarkers...

Descripción completa

Detalles Bibliográficos
Autores principales: Teunissen, Charlotte E., Otto, Markus, Engelborghs, Sebastiaan, Herukka, Sanna-Kaisa, Lehmann, Sylvain, Lewczuk, Piotr, Lleó, Alberto, Perret-Liaudet, Armand, Tumani, Hayrettin, Turner, Martin R., Verbeek, Marcel M., Wiltfang, Jens, Zetterberg, Henrik, Parnetti, Lucilla, Blennow, Kaj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855933/
https://www.ncbi.nlm.nih.gov/pubmed/29544527
http://dx.doi.org/10.1186/s13195-018-0359-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855933/
https://www.ncbi.nlm.nih.gov/pubmed/29544527
http://dx.doi.org/10.1186/s13195-018-0359-x

Ejemplares similares